Szabon, A. Warfarin Versus DOACs in the Prevention of Thromboembolic Stroke in Patients With Afib. : Warfarin Versus DOACs in the Prevention of Thromboembolic Stroke in Patients With Afib. JCANPA 2021, 3, p1-9.